Finance

Lists
Q2 2026 earnings • released • EPS miss -45.64%
See results
NXTC:NASDAQ
NextCure Inc
$6.54
-4.39%
(-0.30) 1D
Aug 11, 10:15:20 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NXTC...
Open
$6.52
High
$6.82
Low
$6.50
Mkt. cap
30.44M
Avg. vol.
4.36M
Volume
50.45K
52-wk high
$15.74
52-wk low
$1.55
EPS
-$18.75
Beta
1.27
Shares outstanding
4.58M
No. of employees
40
Open
$6.52
High
$6.82
Low
$6.50
Mkt. cap
30.44M
Avg. vol.
4.36M
Volume
50.45K
52-wk high
$15.74
52-wk low
$1.55
EPS
-$18.75
Beta
1.27
Shares outstanding
4.58M
No. of employees
40
News stories
From web sources and news partners
About NextCure Inc
CEO-
Employees40
Founded2015
Headquarters-
SectorBiotechnology
Websitenextcure.com
Analyst ratings
Based on 3 analysts giving stock ratings to NXTC in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NXTC in the last 3 months.
Highest
Current $6.54
$25.00 (+282.26%)
Average
$20.00 (+205.81%)
Lowest
$15.00 (+129.36%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$20.00
+205.8%
07/15/2026
Edward Tenthoff
Piper Sandler
Buy
Maintained
$15.00
+129.4%
06/10/2026
Christopher Liu
Lucid Capital
Buy
Maintained
$25.00
+282.3%
06/02/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Upgraded
$18.00
+175.2%
11/07/2025
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$2.80 / -$1.92
-45.64%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.14M
6.80M
6.83M
7.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.81M
2.96M
3.27M
2.59M
Operating expense
8.94M
9.76M
10.10M
10.02M
Total operating expenses
8.94M
9.76M
10.10M
10.02M
Operating income
-8.94M
-9.76M
-10.10M
-10.02M
Other non operating income
-
-
-
202.00K
EBT including unusual items
-8.62M
-9.44M
-9.80M
-14.89M
EBT excluding unusual items
-8.62M
-9.44M
-9.80M
-9.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.62M
-9.44M
-9.80M
-14.89M
Net profit margin
-
-
-
-
Earnings per share
-3.22
-0.81
-1.87
-1.85
Interest and investment income
321.00K
321.00K
309.00K
-
Interest expense
-
-
-
-
Net interest expenses
321.00K
321.00K
309.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.41M
-9.39M
-9.82M
-9.73M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps